We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Digital Heart Twin to Help Treat Dangerous Heart Rhythms

By HospiMedica International staff writers
Posted on 07 Jan 2025

Scar-dependent ventricular tachycardia (VT) is a serious and sporadic heart rhythm disturbance caused by scar tissue in the heart muscle, often resulting from a previous heart attack or genetic heart conditions. More...

Treatment typically involves implanting a defibrillator to shock the heart back to a normal rhythm when needed or using a catheter to ablate (burn) the scar tissue that causes the abnormal rhythms. However, these treatments have significant drawbacks. Defibrillators can’t prevent the recurrence of abnormal rhythms, and repeated shocks can lead to patient discomfort, impacting their quality of life. On the other hand, identifying and treating the scarred areas in the heart can be difficult because scars can form at multiple sites, including deep within the heart, making them hard to identify. Surgeons often map the heart by inserting a catheter to detect electrical pulses that indicate abnormal areas, and sometimes they induce arrhythmias to help locate the problem. Once identified, the surgeon ablates the scar tissue, but complications and high recurrence rates are common if all affected areas are not found and treated.

Now, a new study by researchers at St George’s University of London (London, UK) introduces an innovative approach using computers to create a digital twin of the heart, which can effectively identify scar tissue deep inside the heart. This research, published in the journal Circulation, shows the potential of digital heart twins to revolutionize the treatment of scar-dependent VT, particularly in patients with a history of heart attacks or genetic conditions. The digital heart twin could serve as a non-invasive tool for locating the scarred regions responsible for abnormal rhythms, enabling cardiologists to treat these areas more efficiently and with greater precision.

In their study, the researchers tested whether digital heart twins could predict the locations of abnormal rhythms in patients with scar-dependent VT. Using advanced cardiac imaging and other data, they created computer models that replicated the hearts of 18 patients undergoing catheter ablation for this condition. The patients’ hearts were mapped using a catheter, and abnormal rhythms were induced to help locate problem areas. The digital models were then tested to see if they could predict rhythm disturbances similar to those experienced by the patients. The results showed that the digital heart twins predicted problematic areas with 41% more frequency of abnormalities compared to areas not flagged by the models, suggesting that these digital models could identify potential treatment sites without needing catheter mapping.

Moreover, the digital twins successfully predicted about 80% of the sites in patients’ hearts where electrical signals were slowed, a common sign near scar tissue. This method could reduce the likelihood of abnormal rhythms recurring and the need for additional treatments. The digital twin not only predicts current VT episodes but also forecasts potential future arrhythmias. While the effectiveness of using digital heart twins to guide catheter ablations has not yet been fully tested, the next step would involve a clinical trial comparing current VT ablation practices with a strategy guided by the digital twin from the beginning. However, implementing this procedure may be limited by the sophisticated technology required and the associated costs.

"People are now living with the consequences of heart attacks for many years, so the number of people who need procedures to treat these life-threatening abnormal heart rhythms is rising," said lead study author Dr. Michael Waight, a cardiology registrar at St George's University of London. "If digital twins were to become a reality, it could offer a safer and potentially more effective means of treatment."

The digital heart twin "gives you a road map of areas to focus on. It's an incredibly powerful advancement. It's really moving the field forward, making these procedures a lot more effective and more precise," said Dr. Dhanunjaya Lakkireddy, who was not involved in the research. "If you are able to successfully eliminate these areas that are potentially sites of ventricular tachycardias, you can reduce the time of the procedure and go precisely to the areas that are important with minimal unnecessary ablation. This could potentially improve overall morbidity and mortality with a higher success rate and result in dramatically improved patient outcomes."


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Vessel Sealing Instrument
ERGOseal
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.